FDA approves breakthrough pancreatic cancer treatment

The FDA has approved a new once-daily pill called Racin-Q for patients with advanced pancreatic cancer that has spread to other organs. This breakthrough treatment targets specific gene mutations to stop cancer cell growth, potentially doubling survival rates from seven months to 13 months for those who have already undergone standard chemotherapy.